MNMD - Mergers and acquisitions

FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, April 13, 2022 /PRNewswire/ -- Anxiety disorders are the most common mental illness in the US, affecting approximately 40 million adults each year, and despite the abundance of antianxiety medications available, treatment resistance occurs in roughly 30% of patients. Anxiety disorders have a significant economic impact on the US healthcare system, costing between $42.3 billion and $46.6 billion annually, meaning it's essential to find alternative treatment options. Luckily, new research reveals that psychedelics may be the answer. Clinical trial results show that psilocybin, a potent psychedelic, has antidepressant effects

NEW YORK, Sept. 9, 2021 /PRNewswire/ -- National Suicide Prevention Week is here and it's not only an opportunity to talk about mental health, but to also look at potential treatments. Suicide remains a leading cause of death in the US and mainstream medicine is continuing to look at unconventional mental health treatments like psychedelic-assisted psychotherapy in a new light. Psychedelic-assisted treatment programs have grown in scope and effectiveness, with several key players at the forefront. Revitalist Lifestyle and Wellness Ltd. (CSE:CALM) provides psychedelic treatment programs throughout the United States through public and private clients. COMPASS Pathways PLC (NASDAQ:CMPS) is anot